Pulished Date August, 2019
ID: 167
Share on
Share on

Asia Pacific Biomarkers Market Research Report – segmented by Product, By Type, By Disease Indications & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Analysis on Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: August, 2019
ID: 167
Pages: 145

APAC Biomarkers Market Size & Growth (2019 - 2024)

The size of the biomarkers market in the Asia Pacific region is predicted to reach USD 12.15 billion by 2024 from USD 5.74 billion in 2019 growing at a CAGR of 16.20% during the forecast period 2019-2024.

Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.

Rising demand for diagnostic tests to aware of health conditions, an increasing number of cancer patients, growing focus of foreign pharmaceutical companies on the Asian market, and increasing involvement of universities & research institutes are driving the growth of the biomarkers market in Asia-Pacific region. In addition, the growing demand for advanced healthcare facilities in certain Asian countries such as India & China and a rising number of clinical trials are further stimulating the growth of biomarkers market in the Asia-Pacific region.

However, the low adoption of advanced biomarkers tests and the high cost of biomarkers developments & validation are restraining the growth of the biomarkers market in the Asia-Pacific region.

This research report segmented and sub-segmented into the following categories:

  • By Product: Consumables, Services, Software & Growth Hormone Therapy
  • By Type: Safety Biomarkers, Efficacy Biomarkers & Validation Biomarkers
  • By Application: Diagnostics Development, Drug Discovery and Development, Personalised Medicine, Disease Risk Assessment & Other Applications.
  • By Disease Indications: Cancer, Cardiovascular Disorders, Neurological disorders, Immunological Disorders & Other Diseases
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Noteworthy companies operating in the Asia Pacific Biomarkers Market profiled in this report are Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France) and Signosis, Inc. (U.S.)

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1          Product                                               

                                5.1.1 Introduction                                           

                                5.1.2 Consumables                                         

                                5.1.3 Software                                  

                                5.1.4 Services     Growth Hormone Therapy                         

                5.2          Type                                     

                                5.2.1 Introduction                                           

                                5.2.2 Safety Biomarkers                                               

                                5.2.3 Efficacy Biomarkers                                             

                                5.2.4 Validation Biomarkers                                        

                5.3          Application                                        

                                5.3.1 Introduction                                           

                                5.3.2 Diagnostics Development                                 

                                5.3.3 Drug Discovery and Development                                

                                5.3.4 Personalised Medicine                                      

                                5.3.5 Disease Risk Assessment                                  

                                5.3.6 Other Applications                                               

                5.4          Disease Indications                                        

                                5.4.1 Introduction                                           

                                5.4.2 Cancer                                      

                                5.4.3 CardiovascularDisorders                                    

                                5.4.4 Neurological Disorders                                       

                                5.4.5 Immunological Disorders                                  

                                5.4.6 Other Diseases                                      

  1. Geographical Analysis

                6.3 Asia-Pacific                                                 

                                6.1 Introduction                                               

                                6.2 China                                             

                                6.3 India                                              

                                6.4 Japan                                            

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 Bio-Rad Laboratories (U.S.)                                 

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Qiagen N.V. (Netherlands)                                  

                8.3 Enzo Biochem (U.S.)                                               

                8.4 PerkinElmer, Inc. (U.S.)                                         

                8.5 Merck & Co, Inc. (U.S.)                                          

                8.6 EKF Diagnostics Holdings plc. (U.S.)                                  

                8.7 Meso Scale Diagnostics, LLC (U.S.)                                    

                8.8 Singulex, Inc. (U.S.)                                 

                8.9 BioSims Technologies (France)                                           

                8.10 Cisbio Bioassays (France)                                   

                8.11 Signosis, Inc. (U.S.)                                               

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Biomarkers Market By Region, From 2019-2024 ( USD Billion )
  2. Asia-Pacific Biomarkers Market By Product, From 2019-2024 ( USD Billion )
  3. Asia-Pacific Consumables Market By Region, From 2019-2024 ( USD Billion )
  4. Asia-Pacific Software Market By Region, From 2019-2024 ( USD Billion )
  5. Asia-Pacific Services Market By Region, From 2019-2024 ( USD Billion )
  6. Asia-Pacific Biomarkers Market By Type, From 2019-2024 ( USD Billion )
  7. Asia-Pacific Safety Biomarkers Market By Region, From 2019-2024 ( USD Billion )
  8. Asia-Pacific Efficacy Biomarkers Market By Region, From 2019-2024 ( USD Billion )
  9. Asia-Pacific Validation Biomarkers Market By Region, From 2019-2024 ( USD Billion )
  10. Asia-Pacific Biomarkers Market By Application, From 2019-2024 ( USD Billion )
  11. Asia-Pacific Diagnostics Development Market By Region, From 2019-2024 ( USD Billion )
  12. Asia-Pacific Drug Discovery and Development Market By Region, From 2019-2024 ( USD Billion )
  13. Asia-Pacific Personalised Medicine Market By Region, From 2019-2024 ( USD Billion )
  14. Asia-Pacific Disease Risk Assessment Market By Region, From 2019-2024 ( USD Billion )
  15. Asia-Pacific Other Applications Market By Region, From 2019-2024 ( USD Billion )
  16. Asia-Pacific Biomarkers Market By Disease Indications, From 2019-2024 ( USD Billion )
  17. Asia-Pacific Cancer Market By Region, From 2019-2024 ( USD Billion )
  18. Asia-Pacific Cardiovascular Disorders Market By Region, From 2019-2024 ( USD Billion )
  19. Asia-Pacific Neurological Disorders Market By Region, From 2019-2024 ( USD Billion )
  20. Asia-Pacific Immunological Disorders Market By Region, From 2019-2024 ( USD Billion )
  21. Asia-Pacific Other Diseases Market By Region, From 2019-2024 ( USD Billion )
  22. China Biomarkers Market By Product, From 2019-2024 ( USD Billion )
  23. China Biomarkers Market By Type, From 2019-2024 ( USD Billion )
  24. China Biomarkers Market By Application, From 2019-2024 ( USD Billion )
  25. China Biomarkers Market By Disease Indications, From 2019-2024 ( USD Billion )
  26. India Biomarkers Market By Product, From 2019-2024 ( USD Billion )
  27. India Biomarkers Market By Type, From 2019-2024 ( USD Billion )
  28. India Biomarkers Market By Application, From 2019-2024 ( USD Billion )
  29. India Biomarkers Market By Disease Indications, From 2019-2024 ( USD Billion )
  30. Japan Biomarkers Market By Product, From 2019-2024 ( USD Billion )
  31. Japan Biomarkers Market By Type, From 2019-2024 ( USD Billion )
  32. Japan Biomarkers Market By Application, From 2019-2024 ( USD Billion )
  33. Japan Biomarkers Market By Disease Indications, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample